Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
4 August 2016
Header
Header image
News

News

EFPIA statement on the EMA report "Adaptive pathways: key learnings and next steps"
03 August 2016

EFPIA welcomes the report's statement that adaptive pathways can foster multi-stakeholder dialogue, bringing regulators, interested HTAs, healthcare professionals and patients. We also note the project's [...] Read more

Events calendar

Events Calendar

3rd EUCROF Conference - Flying to 2020: Managing Turbulences of Innovation and Change
From 17/10/2016 to 18/10/2016 (Prague)

The third EUCROF International Conference builds on the success of our previous Conferences in Brussels and Paris. It is the variety of topics related to clinical research that offers the attendees an exceptional opportunity to listen and learn about the "Quo vadis" of clinical research in Europe.

Read more

Events Calendar

IMI Stakeholder Forum 2016
From 28/09/2016 to 29/09/2016 (Brussels, Belgium)

Every year, the IMI Stakeholder Forum gathers IMI’s stakeholders in health and medicines R&D and provides them with an opportunity to learn about and discuss IMI's latest activities and plans. 

On Wednesday 28 September, the event will start at 13:00. The programme will focus on IMI's latest initiatives and results, introduce the topics of the upcoming Call for proposals and facilitate partnering opportunities for applicants.

On Thursday 29 Septemberparallel consultative workshops on strategic research areas will bring together IMI stakeholders to shape together the future of IMI’s programme. The workshops will cover:

Please download the draft agenda  

Read more

Events Calendar

FT Global Pharmaceutical and Biotechnology Conference
From 15/11/2016 to 16/11/2016 (London, UK)

The FT Global Pharmaceutical and Biotechnology Conference, now in its 34th successful year, brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry and the business models and transformation strategies that will be needed to survive and thrive in an industry in flux.

Transformational shifts in healthcare markets herald challenges as well as opportunities ahead for the global life science industry. Considerations around value and outcomes of drug and other medical interventions are becoming a part of the fabric of the industry as health technology assessment and integrated care models gain traction in a growing number of markets.

For more information, click here.

Read more

Events Calendar

Optimising the Development of ATMPs to Meet Patient Needs - The fifth annual regulatory conference organised by the European Biopharmaceutical Enterprises (EBE) in collaboration with the European Medicines Agency (EMA)
On 16/12/2016 (London, UK)

Europe is a world-leader in the development of cutting edge Advanced Therapies Medicinal Products (ATMPs) including gene therapies. This conference, organised in collaboration with the EMA, will feature a gathering of international thought-leaders who will highlight initiatives to improve the access to ATMPs for patients, as well as outline the needs for their development and commercialisation within the EU.

For more information on the programme and to register, click here.

Read more

What we are reading

What we are reading

Adaptive pathways: key learnings and next steps
04 August 2016 (EMA)

EMA publishes report on pilot project and will organise a workshop in December to further explore concept

The European Medicines Agency (EMA) has published a final report on the experience gained during its pilot project on adaptive pathways, a product development concept for medicines that address patients’ unmet medical needs.

Read more

What we are reading

Saving antibiotics for when they are really needed: the Dutch example
04 August 2016 (BMJ)

Doctors have responded well to the call to reduce unnecessary antibiotic prescriptions. But what about farming? The Dutch have shown that antibiotic use can be slashed in agriculture too. So why isn’t everybody doing it? 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail